📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor. (2021)

First Author: Skwarska A

Attributed to: Chemical bioreductive approaches to targeted radiosensitisation and imaging of tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.chembiol.2021.04.004

PubMed Identifier: 33910023

Publication URI: http://europepmc.org/abstract/MED/33910023

Type: Journal Article/Review

Volume: 28

Parent Publication: Cell chemical biology

Issue: 9

ISSN: 2451-9448